Gene · 429
Papers4,495
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 4,495
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Application of Small Molecules in the Central Nervous System Direct Neuronal Reprogramming. | Front Bioeng Biotechnol | 2022 | 35875485 | PubTator, text mining | PubMed |
| Application of Multi-Omics Approach in Sarcomas: A Tool for Studying Mechanism, Biomarkers, and Therapeutic Targets. | Front Oncol | 2022 | 35875106 | PubTator, text mining | PubMed |
| Revealing the mystery of persistent smell loss in Long COVID patients. | Int J Biol Sci | 2022 | 35874953 | PubTator, text mining | PubMed |
| EZH2 regulates a SETDB1/ΔNp63α axis via RUNX3 to drive a cancer stem cell phenotype in squamous cell carcinoma. | Oncogene | 2022 | 35864175 | PubTator, text mining | PubMed |
| Neuropilin-2 axis in regulating secretory phenotype of neuroendocrine-like prostate cancer cells and its implication in therapy resistance. | Cell Rep | 2022 | 35858551 | PubTator, text mining | PubMed |
| Interrogating glioma-M2 macrophage interactions identifies Gal-9/Tim-3 as a viable target against PTEN-null glioblastoma. | Sci Adv | 2022 | 35857445 | PubTator, text mining | PubMed |
| PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition. | J Exp Clin Cancer Res | 2022 | 35836243 | PubTator, text mining | PubMed |
| FGF8-FGFR1 signaling regulates human GnRH neuron differentiation in a time- and dose-dependent manner. | Dis Model Mech | 2022 | 35833364 | PubTator, text mining | PubMed |
| NOTCH1 signaling regulates the latent neurogenic program in adult reactive astrocytes after spinal cord injury. | Theranostics | 2022 | 35832093 | PubTator, text mining | PubMed |
| TOP2B Is Required to Maintain the Adrenergic Neural Phenotype and for ATRA-Induced Differentiation of SH-SY5Y Neuroblastoma Cells. | Mol Neurobiol | 2022 | 35831557 | PubTator, text mining | PubMed |
| CDK7 Inhibition Synergizes with Topoisomerase I Inhibition in Small Cell Lung Cancer Cells by Inducing Ubiquitin-Mediated Proteolysis of RNA Polymerase II. | Mol Cancer Ther | 2022 | 35830858 | PubTator, text mining | PubMed |
| Investigating the Effect of Estradiol Levels on the Risk of Breast, Endometrial, and Ovarian Cancer. | J Endocr Soc | 2022 | 35822202 | PubTator, text mining | PubMed |
| Pulmonary Neuroendocrine Cells and Small Cell Lung Carcinoma: Immunohistochemical Study Focusing on Mechanisms of Neuroendocrine Differentiation. | Acta Histochem Cytochem | 2022 | 35821751 | PubTator, text mining | PubMed |
| HumanMine: advanced data searching, analysis and cross-species comparison. | Database (Oxford) | 2022 | 35820040 | PubTator, text mining | PubMed |
| SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk. | Cancer Discov | 2022 | 35819319 | PubTator, text mining | PubMed |
| Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1. | Nat Cancer | 2022 | 35817829 | PubTator, text mining | PubMed |
| Comprehensive genetic analysis of histological components of combined small cell carcinoma. | Thorac Cancer | 2022 | 35815661 | PubTator, text mining | PubMed |
| Lung Models to Evaluate Silver Nanoparticles' Toxicity and Their Impact on Human Health. | Nanomaterials (Basel) | 2022 | 35808152 | PubTator, text mining | PubMed |
| Effects of Psychotropic Drugs on Ribosomal Genes and Protein Synthesis. | Int J Mol Sci | 2022 | 35806181 | PubTator, text mining | PubMed |
| BHLHE22 Expression Is Associated with a Proinflammatory Immune Microenvironment and Confers a Favorable Prognosis in Endometrial Cancer. | Int J Mol Sci | 2022 | 35806162 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/429/papers?page=58